| Marktkapitalisatie | 152 mln. 132 mln. 123 mln. 113 mln. 213 mln. 14,47 mld. 217 mln. 1,45 mld. 569 mln. 7,22 mld. 570 mln. 558 mln. 23,81 mld. | k/w-verhouding 2027 * |
-
| k/w-verhouding 2028 * | - |
|---|---|---|---|---|---|
| Bedrijfswaarde | 129 mln. 112 mln. 104 mln. 95,87 mln. 181 mln. 12,27 mld. 184 mln. 1,23 mld. 482 mln. 6,12 mld. 483 mln. 473 mln. 20,18 mld. | EV/omzet 2027 * |
-
| EV/omzet 2028 * | - |
| Vrij verhandelbaar |
98,57% | Dividendrendement 2027 * |
-
| Dividendrendement 2028 * | - |
Recentste transcriptie: Depomed Inc
| 1 dag | -9,45% |
| Bestuurder | Titel | Leeftijd | Van |
|---|---|---|---|
Ravi Yadavar
BRD | Directeur/Bestuurslid | 26 | 16-06-2026 |
Punit Patel
BRD | Directeur/Bestuurslid | - | 16-06-2026 |
Toevoegen aan een lijst 0 geselecteerde | Verschil (%) | Varia. 5d. | Varia. 1j. | Varia. 3j. | Kap.($) | |
|---|---|---|---|---|---|---|
| -9,45% | +3,54% | - | - | 152 mln. | ||
| -2,39% | -6,36% | +45,82% | +149,66% | 1.024 mld. | ||
| -0,76% | -4,34% | +48,74% | +49,09% | 618 mld. | ||
| -2,33% | -4,60% | +24,30% | +64,44% | 443 mld. | ||
| +0,68% | +0,25% | +38,47% | +31,95% | 349 mld. | ||
| -1,66% | -1,89% | +32,18% | +37,17% | 297 mld. | ||
| -8,96% | -9,23% | +3,57% | +3,64% | 264 mld. | ||
| -1,37% | -5,71% | -2,10% | -44,43% | 209 mld. | ||
| -1,63% | +0,69% | +25,48% | +64,23% | 208 mld. | ||
| +0,72% | +0,48% | +14,53% | +73,64% | 162 mld. | ||
| Gemiddelde | -2,82% | -1,35% | +25,66% | +47,71% | 397,08 mld. | |
| Gewogen gemiddelde per kap. | -1,96% | -2,17% | +33,29% | +70,34% |
| 2027 * | 2028 * | |
|---|---|---|
| Omzet | - | - |
| Nettowinst (verlies) | 400K 348K 325K 298K 562K 38,13 mln. 572K 3,83 mln. 1,5 mln. 19,01 mln. 1,5 mln. 1,47 mln. 62,71 mln. | - |
| Nettoschuld | - | - |
Werknemers
-
Sector
Farmaceutische producten

















